// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Pilot study to investigate the tolerability and efficacy of dietary manipulation in patients with gastroparesis and systemic sclerosis

Kathryn Biddle - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Scleroderma

Cyanocobalamin

Prevalence and distinct clinical phenotype of concomitant sarcoidosis with other autoimmune rheumatic diseases

Kristina E N Clark - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Developing a molecular classifier for scleroderma spectrum disorders to augment clinical categorisation

Kristina E N Clark - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Feasibility study of photoacoustic imaging for measurement of finger artery structure in healthy controls and patients with systemic sclerosis

Andrea K Murray - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Clinical significance of gaining additional specific autoantibodies during follow-up in connective tissue disease

Kristina E N Clark - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Influence of season on patient-reported assessment of Raynaud’s severity in patients with systemic sclerosis

John D Pauling - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Scleroderma

N/A

Whole genome expression analysis from paired samples of keloidal morphea and systemic sclerosis skin identifies key scleroderma candidate genes

Kristina E N Clark - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Two cases of rapidly progressive diffuse cutaneous systemic sclerosis treated with autologous haematopoietic stem cell transplant

Edward J Davies - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Role of mechanosensing in macrophage activation in systemic sclerosis

Kristina L Krogmannova - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Scleroderma

IL-4

Management of adults with primary Sjögren’s syndrome: an audit based on national guidelines in a tertiary centre

Jack Wildman - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Sjogren's syndrome

N/A

Designing a diet interventional study for autoimmune rheumatic disease: asking patients what they think

Lucia Martin-Gutierrez - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Validation of complex immunophenotyping stratification of patients with lupus and Sjögren’s syndrome with therapeutic potential

Lucia Martin-Gutierrez - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Sjogren's syndrome

N/A

Know your vaccines: a clinical audit on uptake of vaccinations in systemic lupus erythematosus patients

Eltho E Varughese - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Clinical and serological features of increased interferon-alpha activity in an unselected connective tissue disease cohort

John A Reynolds - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interferon alpha

Patient perceptions of physical activity in systemic lupus erythematosus: a qualitative exploratory study

Chloe Keith-Jopp - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Antiphospholipase A2 receptor antibodies, a marker of idiopathic membranous nephropathy, are not present in membranous lupus nephritis

Filipa Farinha - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Membranous glomerulonephritis

N/A

Cardiovascular disease in SLE: what do patients think about using diet as a therapeutic?

George Robinson - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sleep disturbances in lupus patients

Asim Khan - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Prevalence of fibromyalgia in a cohort of renal and non-renal systemic lupus erythematosus patients

Ammar Almathkouri - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Patients’ perspectives on self-management of axial spondyloarthritis fatigue

Doriana Xhaxho - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Copyright © 2026. QuantiNova All rights reserved